• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Long-term efficiency of opioid medication in patients with chronic non-cancer-associated pain. Results of a survey 5 years after onset of medical treatment].

作者信息

Maier C, Schaub C, Willweber-Strumpf A, Zenz M

机构信息

Universitätsklinik für Anaesthesiologie, Intensiv- und Schmerztherapie, Berufsgenossenschaftliche Kliniken Bergmannsheil, Bochum.

出版信息

Schmerz. 2005 Oct;19(5):410-7. doi: 10.1007/s00482-005-0432-9.

DOI:10.1007/s00482-005-0432-9
PMID:16133299
Abstract

UNLABELLED

A total of 121 patients with at least a 3-year history of opioid use were evaluated by a standardized interview during a clinical visit or telephone call. Assessed items were the present and former drug medication, daily doses, withdrawals, contentment with the treatment, positive/negative treatment effects, average/maximum pain and others.

STATISTICS

chi(2), ANCOVA and survival analysis. Of 121 patients (frequency of withdrawal 14.8% mainly due to lack of efficacy) with an average treatment time of 66 months (37-105 months; 80,264 days; 87% more than 5 years), 103 (85%) still took an opioid step II or III according to the WHO analgesic ladder. Patients further treated in the pain clinic stopped significantly less frequently than patients treated by GPs or other non-specialised physicians (5 versus 23%). Patients with long-term opioid intake revealed significantly lower pain intensity and higher contentment with the pain management and achieved improvement (global, quality of life and physical state). Changes of opioid dosages during the 5 years were inconsistent (no change 33%, decrease 16%, slight increase 27%, high increase 19%). However, the number of patients with high dose increased from 6 to 23 due to significant loss of efficacy (proved in the morphine subgroup, p<0.05). The survey demonstrates a very low frequency of withdrawal in patients with long-term opioid medication after initial response without evidence for tolerance development, especially if their treatment is controlled in a pain centre.

摘要

相似文献

1
[Long-term efficiency of opioid medication in patients with chronic non-cancer-associated pain. Results of a survey 5 years after onset of medical treatment].
Schmerz. 2005 Oct;19(5):410-7. doi: 10.1007/s00482-005-0432-9.
2
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).阿片类药物与老年人慢性重度疼痛的管理:一个国际专家小组的共识声明,重点关注世界卫生组织第三阶梯临床最常用的六种阿片类药物(丁丙诺啡、芬太尼、氢吗啡酮、美沙酮、吗啡、羟考酮)。
Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.
3
[Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth].[贝鲁特法国主宫医院阿片类镇痛药的处方模式]
Encephale. 2016 Dec;42(6):511-516. doi: 10.1016/j.encep.2016.05.010. Epub 2016 Oct 21.
4
Fentanyl buccal tablet.芬太尼口腔崩解片
Drugs Today (Barc). 2008 Jan;44(1):41-54. doi: 10.1358/dot.2008.44.1.1178469.
5
Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.鼻内注射50至200微克芬太尼喷雾剂对癌症患者爆发性疼痛的疗效和耐受性:一项III期、多国、随机、双盲、安慰剂对照、交叉试验,并有一个为期10个月的开放标签扩展治疗期。
Clin Ther. 2009 Jun;31(6):1177-91. doi: 10.1016/j.clinthera.2009.05.022.
6
[Limited efficacy of opioids in chronic musculoskeletal pain].[阿片类药物在慢性肌肉骨骼疼痛中的疗效有限]
Schmerz. 2004 Dec;18(6):506-14. doi: 10.1007/s00482-004-0314-6.
7
Comparative study between 2 protocols for management of severe pain in patients with unresectable pancreatic cancer: one-year follow-up.两种不可切除胰腺癌患者重度疼痛管理方案的对比研究:一年随访。
Clin J Pain. 2013 Sep;29(9):807-13. doi: 10.1097/AJP.0b013e3182757673.
8
Morphine as first medication for treatment of cancer pain.吗啡作为治疗癌痛的首选药物。
Braz J Anesthesiol. 2014 Jul-Aug;64(4):236-40. doi: 10.1016/j.bjane.2013.06.016. Epub 2014 Feb 11.
9
American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.美国介入性疼痛医师学会(ASIPP)慢性非癌痛阿片类药物处方责任指南:第一部分——证据评估。
Pain Physician. 2012 Jul;15(3 Suppl):S1-65.
10
Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.阿片类药物用于慢性非癌性疼痛的管理:美国介入性疼痛医师协会(ASIPP)指南更新
Pain Physician. 2008 Mar;11(2 Suppl):S5-S62.

引用本文的文献

1
Misuse, Abuse and Medication Errors' Adverse Events Associated with Opioids-A Systematic Review.与阿片类药物相关的误用、滥用及用药错误不良事件——一项系统评价
Pharmaceuticals (Basel). 2024 Jul 31;17(8):1009. doi: 10.3390/ph17081009.
2
The opioid epidemic and national guidelines for opioid therapy for chronic noncancer pain: a perspective from different continents.阿片类药物流行与慢性非癌性疼痛的阿片类药物治疗国家指南:来自不同大陆的观点。
Pain Rep. 2017 May 12;2(3):e599. doi: 10.1097/PR9.0000000000000599. eCollection 2017 May.
3
An exploration of opioid medication management for non-malignant pain in primary care.

本文引用的文献

1
[Risk factors for substance abuse and dependence in opioid therapy for chronic noncancer-related pain].
Schmerz. 2005 Oct;19(5):434-6, 437-40. doi: 10.1007/s00482-005-0426-7.
2
Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials.阿片类激动剂治疗非恶性来源神经病理性疼痛的疗效与安全性:随机对照试验的系统评价与荟萃分析
JAMA. 2005 Jun 22;293(24):3043-52. doi: 10.1001/jama.293.24.3043.
3
Opioids in chronic non-cancer pain, indications and controversies.慢性非癌性疼痛中的阿片类药物:适应证与争议
基层医疗中阿片类药物用于非恶性疼痛管理的探索
Br J Pain. 2015 Aug;9(3):181-9. doi: 10.1177/2049463715574111.
4
[Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks].[慢性非癌性疼痛的长期阿片类药物治疗。对研究持续时间至少为26周的开放标签延长期试验中的疗效、耐受性和安全性进行系统评价和荟萃分析]
Schmerz. 2015 Feb;29(1):96-108. doi: 10.1007/s00482-014-1452-0.
5
Long-term opioid use in non-cancer pain.非癌性疼痛的长期阿片类药物使用。
Dtsch Arztebl Int. 2014 Oct 24;111(43):732-40. doi: 10.3238/arztebl.2014.0732.
6
Lack of correlation between opioid dose adjustment and pain score change in a group of chronic pain patients.一组慢性疼痛患者中,阿片类药物剂量调整与疼痛评分变化之间缺乏相关性。
J Pain. 2013 Apr;14(4):384-92. doi: 10.1016/j.jpain.2012.12.012. Epub 2013 Feb 26.
7
[Physicians do not treat averages--but therapy responders!].医生治疗的不是平均情况,而是治疗有反应者!
Schmerz. 2012 Feb;26(1):5-7. doi: 10.1007/s00482-011-1134-0.
8
[Epidemiology of chronic non-malignant pain in Germany].[德国慢性非恶性疼痛的流行病学]
Schmerz. 2011 Feb;25(1):26-44. doi: 10.1007/s00482-010-1011-2.
9
[Addition is also a disease].加法也是一种疾病。
Schmerz. 2008 Dec;22(6):639-43. doi: 10.1007/s00482-008-0716-y.
Eur J Pain. 2005 Apr;9(2):127-30. doi: 10.1016/j.ejpain.2004.05.013.
4
Opioids in chronic non-cancer pain: systematic review of efficacy and safety.阿片类药物用于慢性非癌性疼痛:疗效与安全性的系统评价
Pain. 2004 Dec;112(3):372-380. doi: 10.1016/j.pain.2004.09.019.
5
Opioid therapy for chronic pain.用于慢性疼痛的阿片类药物治疗。
N Engl J Med. 2003 Nov 13;349(20):1943-53. doi: 10.1056/NEJMra025411.
6
Recommendations for using opioids in chronic non-cancer pain.慢性非癌性疼痛中使用阿片类药物的建议。
Eur J Pain. 2003;7(5):381-6. doi: 10.1016/S1090-3801(02)00143-X.
7
[Computer-assisted tool (QUAST) for documentation and quality assurance in pain treatment].[用于疼痛治疗文档记录与质量保证的计算机辅助工具(QUAST)]
Schmerz. 2000 Dec;14(6):401-15. doi: 10.1007/s004820000011.
8
Morphine responsiveness, efficacy and tolerability in patients with chronic non-tumor associated pain - results of a double-blind placebo-controlled trial (MONTAS).慢性非肿瘤相关性疼痛患者的吗啡反应性、疗效及耐受性——一项双盲安慰剂对照试验(MONTAS)的结果
Pain. 2002 Jun;97(3):223-233. doi: 10.1016/S0304-3959(02)00020-9.
9
Effects of IV morphine in central pain: a randomized placebo-controlled study.
Neurology. 2002 Feb 26;58(4):554-63. doi: 10.1212/wnl.58.4.554.
10
The effect of opioids on phantom limb pain and cortical reorganization.
Pain. 2001 Feb 1;90(1-2):47-55. doi: 10.1016/s0304-3959(00)00385-7.